BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, November 25, 2024
See today's BioWorld
Home
» Other news to note for Jan. 4, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 4, 2022
Jan. 4, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advicenne, Affiris, Allarity, Amyris, Arbor, Aveo, Astrazeneca, Bayer, Biogen, Biologics of Jemincare, Biomx, Biorestorative, Cognition, Cumberland, Evotec, Frontier, Genocea, Genprex, Green Cross, Hansa, Hoth, Immunitybio, Ionis, J&J, Kyverna, Kyowa, Merck, Oncoheroes, Ovid, Prometheus, Rivaara, Santhera, Sperogenix, Soligenix, TCR2, Tonix, Vaxil.
BioWorld
Briefs
Other news to note
Coronavirus